Some links and some HealthCareStocks worth a look

  • Gannon and Hoang writing about MSC Industrial Direct (MSM): A Metalworking Supply Company (link)
  • The Brooklyn Investor Blog is active again (link I), (link II)
  • I believe my pig whistles: Muddy Water, who famously short Ströer, released Ströer AGM Transcript (link)

ten Doornkaat: You then said you had an investigation conducted by Ernst & Young (EY). This is the same company that prepared the annual financial statements. What did you expect? That they would come forward and say, Oops, sorry, we’ve made a mistake, we’re returning our auditor’s licence to practice? This is laughable.

Müller:
No need. The technology is so sophisticated that I can hear you even when I’m
peeing.
ten Doornkaat:
Good. Then perhaps you can come up with some answers while you’re peeing, too.
(Laughter)
Tüngler:  A clear opinion has emerged, which we at the DSW share, that the numbers
have not been manipulated, massaged or falsified.

 

Searching for cheap Health Care Stocks:

Looking on “Falling-Knife-Charts” and thinking something is cheap is the mother of  anchoring bias … but anyway:

 

Novo Nordisk

Novo Nordisk is almost down to 52W Low

Novo_Nordisc is down on 52W low.PNG

Novo Nordisk is a global healthcare company with more than 90 years innovation and leadership in diabetes care. (link) Novo Nordisk is almost down to 52W Low

 

Perrigo

As Seth Klarman writes in his book: “A frequently used but flawed shortcut method of valuing a going concern is known as private-market value. This is an investor’s assessment of the price that a sophisticated businessperson would be willing to pay for a business” … but anyway:

Mylan NV failed in its $26 billion hostile bid for Perrigo Co. on Friday, falling short in its biggest attempt yet to join the wave of consolidation sweeping the generic drug industry. (link Bloomberg) Perrigo Company is down to 52W Low, maybe worth a look?

Perrigo down_MYL.PNG

Perrigo Company 2Q result (link)

Outlook:

Primarily due to revised expectations for the Rx segment, the Company now expects calendar year 2016 reported earnings per diluted share in the range of $0.26 to $0.56 (compared to a loss of $0.23 in calendar year 2015) and expects calendar year 2016 adjusted earnings per diluted share in the range of $6.85 to $7.15.

Advertisements

3 thoughts on “Some links and some HealthCareStocks worth a look

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s